logo
ADVERTISEMENT

Kenyan babies' deadly wait for heart surgery

A third of infants born with damaged hearts die not because they can’t be treated, but because help comes too late.

image
by JOHN MUCHANGI

Health09 October 2025 - 00:17
ADVERTISEMENT

In Summary


  • These patients waited an average of 59 days for their turn in the operating theatre, while patients recommended for catheterisation waited an average of 95 days. 36 per cent died waiting.
Vocalize Pre-Player Loader

Audio By Vocalize

Researchers reviewing 1,703 cases at Kenyatta National Hospital found that only 37 per cent of Kenyan children born with congenital heart disease receive surgery within a year.

Their tiny chests rise and fall in a struggle to keep a steady heartbeat. These babies, at one of Kenyatta National Hospital’s paediatric wards, were born with holes in their hearts or valves that never formed properly. Each gasp of air is a plea for help.

But researchers from the University of Nairobi and KNH, who pored through 1,703 medical records of some of these patients, found that this help takes months to come and often finds many of the patients already dead.

They reviewed records of patients with Congenital Heart diseases (CHD) admitted at KNH from January 2016 to December 2021.

Most of them (53.6 per cent) were under one year old at diagnosis.

CHD is a general term for many birth defects present at birth that affect the normal way the heart works.

 These defects vary in severity from mild, like a small hole in the heart, to complex and severe conditions involving missing or underdeveloped heart parts. They can be detected during pregnancy or may not become apparent until later in life.

“The majority (62.9 per cent) of patients recommended for surgery did not undergo the surgery,” said the team led by Dr Bonface Osano, a lecturer and paediatric cardiologist at the University of Nairobi.

The review found that only 37 per cent of the children who needed surgery received it within a year.

These patients waited an average of 59 days for their turn in the operating theatre, while patients recommended for catheterisation waited an average of 95 days.

Catheterisation is often performed to treat CHD and avoid open-heart surgery.

The few referred abroad were not lucky either. Their wait stretched to an agonising 349 days.

Dr Osano and his colleagues said 615 (36.1 per cent) of patients died within a year of diagnosis, waiting for the intervention that could save their lives.

“The lengthy time period between diagnosis and intervention is mainly due to issues related to access and affordability,” the authors noted. “Delayed diagnosis and long waiting time to intervention may lead to deaths before intervention is undertaken or poor outcomes when the intervention is finally undertaken.”

Dr Osano’s report, titled “One-year outcomes and intervention waiting time of patients admitted with congenital heart disease at Kenyatta National Hospital, Kenya,” is available online ahead of journal publication.

Congenital heart disease affects about eight to 15 babies in every 1,000 live births worldwide, according to the World Health Organization.

KNH is one of only three public facilities in Kenya with the capacity to CHD. The others are Moi Teaching and Referral Hospital in Eldoret and Coast General Teaching and Referral Hospital in Mombasa.

Dr Osano’s team did not blame KNH for the deaths and long wait times.

The hospital has only a few experts serving a large number of patients. Many patients also arrive late when complications have already developed.

In fact, some parents were told that their children were now too sick for surgery. “At diagnosis, 57 were deemed inoperable and were counselled on palliative care,” the report stated, a phrase that means doctors could only manage symptoms, not fix the heart.

Kenya has low diagnostic capability and inadequate facilities for CHDs, leading to delayed diagnosis and appropriate intervention options.

 “The lengthy time period between diagnosis and intervention is mainly due to issues related to access and affordability of these interventions,” the researchers said.

They added: “Additionally, socioeconomic factors like poverty, malnutrition, and the absence of clean water and sanitation exacerbate the susceptibility to CHD complications and infections, which, in turn, elevate mortality rates.”

Patients who survive the long wait often live with anxiety. “Older children and those with Tetralogy of Fallot were more likely to die,” the researchers wrote. Tetralogy of Fallot is one of the most severe forms of congenital heart disease. It leaves babies breathless, their lips turning blue as oxygen fails to reach their blood. A simple operation can correct it, but only if done in time.

Most operations to correct CHD are now routine across the world. In high-income countries, more than 85 to 90 per cent of children who undergo heart surgery for congenital defects survive and go on to live normal lives, says the US Centers for Disease Control and Prevention.

Of the estimated 261,000 global deaths from congenital heart disease in 2017, nearly 70 per cent were infants, and most were in developing regions.

The authors called for immediate action. “There is need to shorten time taken from diagnosis to intervention for patients with CHD and to improve documentation for patients with CHD at KNH,” they said.

Love Health? Stay Connected!

Be part of an exclusive group of enthusiasts! Get fresh content, expert advice and exciting updates in your inbox with our health newsletter.